SCHEMBL5199288

SCHEMBL5199288

Cc1cccc(-c2[nH]c(C(C)C)nc2-c2cccc(-c3ccc([N+](=O)[O-])cn3)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 9/20 0.43
MAPK14 Q16539 5/20 0.39
KDM4E B2RXH2 1/20 0.39
MTOR P42345 1/20 0.38
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ALOX5 P09917 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RIPK2 O43353 1/20 0.35
ACVR1B P36896 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PDE4A P27815 2/20 0.34
PDE4D Q08499 2/20 0.34
PDE4C Q08493 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200009 0.88 TGFBR1 (0.46) TGFBR1MAPK14KDM4EMTORALDH1A1
SCHEMBL5199710 0.83 TGFBR1 (0.44) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL5200721 0.83 TGFBR1 (0.44) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL5198037 0.81 TGFBR1 (0.51) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL5198587 0.80 TGFBR1 (0.51) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL5198169 0.79 TGFBR1 (0.44) TGFBR1MAPK14KDM4EMTORHTT
SCHEMBL6761612 0.78 KDM4E (0.43) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL5199505 0.76 TGFBR1 (0.48) TGFBR1MAPK14KDM4EMTOR
SCHEMBL5199866 0.76 TGFBR1 (0.48) TGFBR1MAPK14KDM4EMTORRIPK2
SCHEMBL6760994 0.76 TGFBR1 (0.45) TGFBR1MAPK14KDM4EMTORRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885MAPK14 2998/4885KDM4E 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.